Cargando…
Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation
BACKGROUND: Genetic determinants of drug response remain stable throughout life and offer great promise to patient-tailored drug therapy. The adoption of pharmacogenetic (PGx) testing in patient care requires accurate, cost effective and rapid genotyping with clear guidance on the use of the results...
Autores principales: | Goh, Liuh Ling, Lim, Chia Wei, Sim, Wey Cheng, Toh, Li Xian, Leong, Khai Pang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207784/ https://www.ncbi.nlm.nih.gov/pubmed/28046094 http://dx.doi.org/10.1371/journal.pone.0169233 |
Ejemplares similares
-
TPMT and NUDT15 testing for thiopurine therapy: A major tertiary hospital experience and lessons learned
por: Goh, Liuh Ling, et al.
Publicado: (2022) -
Missense variant in interleukin-6 signal transducer identified as susceptibility locus for rheumatoid arthritis in Chinese patients
por: Pang Leong, Khai, et al.
Publicado: (2021) -
Review: Influence of the CYP450 Genetic Variation on the Treatment of Psychotic Disorders
por: Carrascal-Laso, Lorena, et al.
Publicado: (2021) -
PARP Inhibitors in Breast and Ovarian Cancer
por: Wang, Samuel S. Y., et al.
Publicado: (2023) -
Copy number variation profiling in pharmacogenetics CYP-450 and GST genes in Colombian population
por: Ramírez, Brian, et al.
Publicado: (2019)